Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Gains from Investment Securities (2020 - 2026)

SkinHealth Systems has reported Gains from Investment Securities over the past 6 years, most recently at $427000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities rose 109.37% to $427000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78000.0 through Dec 2025, up 101.03% year-over-year, with the annual reading at $1.6 million for FY2025, 151.26% up from the prior year.
  • Gains from Investment Securities was $427000.0 for Q4 2025 at SkinHealth Systems, up from -$210000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $199.3 million in Q3 2021 and troughed at -$52.1 million in Q1 2022.
  • The 5-year median for Gains from Investment Securities is -$349000.0 (2025), against an average of $9.2 million.
  • Year-over-year, Gains from Investment Securities surged 3611.03% in 2021 and then tumbled 483.5% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $300000.0 in 2021, then soared by 209.0% to $927000.0 in 2022, then tumbled by 483.5% to -$3.6 million in 2023, then decreased by 28.16% to -$4.6 million in 2024, then soared by 109.37% to $427000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Gains from Investment Securities are $427000.0 (Q4 2025), -$210000.0 (Q3 2025), and $210000.0 (Q2 2025).